KM Financial Solutions | Kaleo expanding access in U.S. to drug to reverse opioid overdose
13881
post-template-default,single,single-post,postid-13881,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Kaleo expanding access in U.S. to drug to reverse opioid overdose

Kaleo expanding access in U.S. to drug to reverse opioid overdose

April 5 (Reuters) – Kaleo Inc, which came under fire last
year for the high price of its device to treat opioid overdoses,
on Thursday said it is expanding nonprescription access to the
Evzio injector and will sell it to U.S. government agencies at a
steep discount.

No Comments

Sorry, the comment form is closed at this time.